LobbyingCardiac Insight lobbying by quarter
Cardiac Insight's latest lobbying report covers Q3 2025, at $10K. Its first report covers Q2 2025; the issues it reports most are Health Issues and Manufacturing.
Cardiac Insight
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q2 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2025 | $20K | 1 |
| Q3 2025 | $10K | 1 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$10K · 2 reports
- Manufacturing$10K · 2 reports
- Medical research and clinical labs$10K · 2 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES2 reports
- SENATE2 reports
Firms it paid
| Firm | ||
|---|---|---|
| Alpine Group Partners | $30K | 2 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| ERIN MENDELSOHN | LD, Rep. Anna Eshoo; Congressional Liaison - FDA | Q3 2025 |
| GREG WALDEN | US Congressman 1999-2021 | Q3 2025 |
| HANNAH SCHMIDT | Professional Staff, House Small Business Cmte | Q3 2025 |
| SHAYNE WOODS | Senior Legislative Assistant, Sen. Tim Scott; Senior Policy Advisor, Rep. Gus Bilirakis | Q3 2025 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 25/10/18for Q3 2025 | Alpine Group Partners | $10K |
| 25/07/17for Q2 2025 | Alpine Group Partners | $20K |
| 25/06/25for Q2 2025 | Alpine Group Partners | Under $5,000 |